SOLUSALT

What this means for you

Not registered yet, but its 13 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99441103

Mark type

Stylized text

Filed

13 Oct 2025

Attorney of record

Aaron D. Hendelman

Goods and services

• Class 001 — Chemicals: chemicals, namely, cyclodextrins for industrial purposes; preparations derived from cyclodextrins, namely, chemicals for industrial purposes and active principles in the nature of active chemical ingredients, complexed by cyclodextrins, for use in the manufacture of pharmaceuticals and medicines; chemicals, namely, cyclodextrins and cyclodextrin derivatives for use in the chemical, plastics, paper, agricultural, horticultural, insulation, packaging, pharmaceutical, cosmetic, fragrance, textile, leather, healthcare, food and paint industries; active pharmaceutical ingredients, namely, salts for use in the manufacture of pharmaceuticals and medicines
• Class 005 — Pharmaceuticals: pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system-related diseases and disorders
• Class 010 — Medical apparatus: wearable drug delivery devices sold empty, namely, subcutaneous pumps for the delivery of medication for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system-related diseases and disorders
• Class 042 — Scientific and technological services: medical and scientific research in the fields of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; platforms for small molecules for controlled delivery of therapeutic agents; medical and scientific research and development in relation to pharmaceuticals and drug delivery platforms; providing scientific information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor; pharmaceutical research and development; drug discovery services; providing medical information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
• Class 044 — Medical, beauty and agricultural services: research and development in the field of computational biology, bioinformatics, genomics, biotechnology, immunology and pharmaceuticals; biomedical research and development services; scientific study and research in the fields of medicine, biomedical technology, and genetics

Owner

• Bexson Biomedical, Inc., Santa Barbara, CA, US

Prosecution history

• 17 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 17 Mar 2026 — NON-FINAL ACTION E-MAILED
• 17 Mar 2026 — NON-FINAL ACTION WRITTEN
• 02 Mar 2026 — ASSIGNED TO EXAMINER
• 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 13 Oct 2025 — APPLICATION FILING RECEIPT MAILED
• 13 Oct 2025 — NEW APPLICATION ENTERED